Round Type
Series B
Miami BeachBiotechnologyDescription
SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical company with a proprietary technology to produce fully human polyclonal antibodies without the need for human plasma donors, today announced it has closed its Series B funding round at $14 million. New investor, global healthcare leader Merck, known as MSD outside the United States and Canada, was joined by South Dakota Equity Partners and several other follow-on and private investors.
Quick answer
SAB Biotherapeutics raised an undisclosed amount in a Series B round, dated July 17, 2020. SAB Biotherapeutics is based in Miami Beach, Florida, United States.
- How much did SAB Biotherapeutics raise?
- SAB Biotherapeutics raised an undisclosed amount in a Series B round on July 17, 2020.
- What does SAB Biotherapeutics do?
- SAB Biotherapeutics (SAB) is a clinical-stage biopharmaceutical company focused on developing fully human, multi-targeted, high-potency immunoglobulins (IgGs), without the need for human donors or convalescent plasma,..
- Where is SAB Biotherapeutics based and how big is it?
- SAB Biotherapeutics is based in Miami Beach, Florida, United States. Fundz records about 62 employees.
- Who are the decision-makers at SAB Biotherapeutics?
- Fundz holds 3 contacts at SAB Biotherapeutics, including the Executive Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as SAB Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Harvard Apparatus Regenerative Technology raised $500K on August 31, 2020.
- VDYNE LLC raised $13M on August 31, 2020.
- Helaina Inc raised $4M (Seed) on August 31, 2020.
- AEON Biopharma raised $25M on August 31, 2020.
- Erasca, Inc. raised $236M (Series B) on August 31, 2020.
- NXPharmagen raised $486K (Seed) on August 31, 2020.
Who to call at SAB Biotherapeutics, and when
A new round usually means SAB Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SAB Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SAB Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SAB Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SAB Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSAB Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.